These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 33334936

  • 41. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [Abstract] [Full Text] [Related]

  • 42. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 43. An innovative corticosteroid/long-acting β2-agonist breath-triggered inhaler: facilitating lung delivery of fluticasone propionate/formoterol fumarate for the treatment of asthma.
    Usmani O, Roche N, Marshall J, Danagher H, Price D.
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder.
    Raimondi AC, Schottlender J, Lombardi D, Molfino NA.
    Chest; 1997 Jul; 112(1):24-8. PubMed ID: 9228352
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy.
    Moretz C, Cole AL, Mu G, Wu B, Guisinger A, Liu Y, Hahn B, Baylis L.
    Int J Chron Obstruct Pulmon Dis; 2020 Jul; 15():2207-2215. PubMed ID: 32982213
    [Abstract] [Full Text] [Related]

  • 51. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP, Hill MR, Vaughan LM, Meltzer EO, Welch MJ, Ostrom NK.
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler.
    Hojo M, Shirai T, Hirashima J, Iikura M, Sugiyama H.
    Pulm Pharmacol Ther; 2016 Apr; 37():43-8. PubMed ID: 26898348
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 56. Risk factors hindering asthma symptom control in Saudi children and adolescents.
    Halwani R, Vazquez-Tello A, Horanieh N, Dulgom S, Al-Aseri Z, Al-Khamis N, Al-Sum Z, Al-Jahdali H, Al-Muhsen S.
    Pediatr Int; 2017 Jun; 59(6):661-668. PubMed ID: 28218986
    [Abstract] [Full Text] [Related]

  • 57. Knowledge, practice pattern and attitude toward asthma management amongst physicians from Nepal, Malaysia, Lebanon, Myanmar and Morocco.
    Chokhani R, Razak A, Waked M, Naing W, Bakhatar A, Khorani U, Gaur V, Gogtay J.
    J Asthma; 2021 Jul; 58(7):979-989. PubMed ID: 32174204
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Jul; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 60. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
    Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Stanford R, Su Z, Sampalis JS.
    Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.